Canada · Delayed Price · Currency is CAD Vext Science Statistics
Total Valuation
Vext Science has a market cap or net worth of CAD 64.40 million. The enterprise value is 104.08 million.
| Market Cap | 64.40M |
| Enterprise Value | 104.08M |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vext Science has 247.68 million shares outstanding. The number of shares has increased by 0.46% in one year.
| Current Share Class | 185.79M |
| Shares Outstanding | 247.68M |
| Shares Change (YoY) | +0.46% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 22.43% |
| Owned by Institutions (%) | 35.40% |
| Float | 101.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.89 |
| PB Ratio | 0.85 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.52 |
| P/OCF Ratio | 4.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.80, with an EV/FCF ratio of 10.54.
| EV / Earnings | -4.79 |
| EV / Sales | 1.43 |
| EV / EBITDA | 6.80 |
| EV / EBIT | n/a |
| EV / FCF | 10.54 |
Financial Position
The company has a current ratio of 0.62, with a Debt / Equity ratio of 0.62.
| Current Ratio | 0.62 |
| Quick Ratio | 0.23 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | 4.80 |
| Interest Coverage | -1.11 |
Financial Efficiency
Return on equity (ROE) is -24.49% and return on invested capital (ROIC) is -5.84%.
| Return on Equity (ROE) | -24.49% |
| Return on Assets (ROA) | -2.48% |
| Return on Invested Capital (ROIC) | -5.84% |
| Return on Capital Employed (ROCE) | -5.47% |
| Weighted Average Cost of Capital (WACC) | 9.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.44 |
Taxes
In the past 12 months, Vext Science has paid 4.54 million in taxes.
| Income Tax | 4.54M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +108.00% in the last 52 weeks. The beta is 0.77, so Vext Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +108.00% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 40.00 |
| Average Volume (20 Days) | 40,380 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vext Science had revenue of CAD 72.54 million and -21.71 million in losses. Loss per share was -0.09.
| Revenue | 72.54M |
| Gross Profit | 24.71M |
| Operating Income | -6.86M |
| Pretax Income | -17.17M |
| Net Income | -21.71M |
| EBITDA | 13.95M |
| EBIT | -6.86M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 7.74 million in cash and 47.42 million in debt, with a net cash position of -39.68 million or -0.16 per share.
| Cash & Cash Equivalents | 7.74M |
| Total Debt | 47.42M |
| Net Cash | -39.68M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | 76.06M |
| Book Value Per Share | 0.31 |
| Working Capital | -14.41M |
Cash Flow
In the last 12 months, operating cash flow was 14.30 million and capital expenditures -4.43 million, giving a free cash flow of 9.87 million.
| Operating Cash Flow | 14.30M |
| Capital Expenditures | -4.43M |
| Depreciation & Amortization | 20.61M |
| Net Borrowing | -5.45M |
| Free Cash Flow | 9.87M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 34.06%, with operating and profit margins of -9.45% and -29.93%.
| Gross Margin | 34.06% |
| Operating Margin | -9.45% |
| Pretax Margin | -23.67% |
| Profit Margin | -29.93% |
| EBITDA Margin | 19.23% |
| EBIT Margin | -9.45% |
| FCF Margin | 13.61% |
Dividends & Yields
Vext Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.46% |
| Shareholder Yield | -0.46% |
| Earnings Yield | -33.71% |
| FCF Yield | 15.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vext Science has an Altman Z-Score of 0.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 5 |